Page last updated: 2024-10-25

2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and Hepatocellular Carcinoma

2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone has been researched along with Hepatocellular Carcinoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ge, L3
Wang, Z3
Wang, M3
Kar, S1
Carr, BI4
Enokimura, N1
Shiraki, K1
Kawakita, T1
Saitou, Y1
Inoue, H1
Okano, H1
Yamamoto, N1
Sugimoto, K1
Nakano, T1

Other Studies

4 other studies available for 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone and Hepatocellular Carcinoma

ArticleYear
Involvement of c-Myc in growth inhibition of Hep 3B human hepatoma cells by a vitamin K analog.
    Journal of hepatology, 2004, Volume: 41, Issue:5

    Topics: Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Extracellular Signal-Regulated MAP

2004
Vitamin K analog (compound 5) induces apoptosis in human hepatocellular carcinoma independent of the caspase pathway.
    Anti-cancer drugs, 2005, Volume: 16, Issue:8

    Topics: Apoptosis; Apoptosis Regulatory Proteins; bcl-X Protein; Carcinoma, Hepatocellular; Caspase Inhibito

2005
Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Journal of cellular physiology, 2006, Volume: 208, Issue:1

    Topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blotting, Western; Butadienes; Carcinom

2006
Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5.
    Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease

2007